Univec, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a UNVC research report →
Price Chart
About the company
Univec, Inc. is a medical device firm that, through its various operating divisions, develops, licenses, and sells products across the United States and internationally. Its primary offerings include a range of auto-disable and safety syringes.
- CEO
- David Dalton
- IPO
- 1997
- Employees
- 3
- HQ
- Owings Mills, MD, US
Get TickerSpark's AI analysis on UNVC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $4.79M
- P/E
- -3.94
- PEG
- -0.01
- P/S
- 52.59
- P/B
- -0.26
- EV/EBITDA
- -4.93
- Div Yield
- 0.00%
- Gross Margin
- 16.10%
- Op Margin
- -1399.25%
- Net Margin
- -1334.32%
- ROE
- 6.83%
- ROIC
- 7.57%
Latest fiscal year · YoY change
- Revenue
- $85.01K+131.0%
- Gross Profit
- $8.06K+296.2%
- Op Income
- $-1,203,115
- Net Income
- $-1,215,374+1.8%
- EPS
- $0.00+100.0%
- OCF Growth
- -28172.5%
- FCF Growth
- -28175.0%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.85
- RSI (14)
- 42
- Avg Volume
- 523.10K
No earnings-call transcripts are available for UNVC yet.
- Free Float
- 36.2%
- Shares Outstanding
- 2.52B
- Float Shares
- 912.85M
Our UNVC coverage
Recent articles, reports, and earnings notes.
No research on UNVC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate UNVC report →Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.